Currently, patients who can benefit from proton therapy have to travel overseas to receive it. Funding for proton therapy overseas is available through the Australian Medical Treatment Overseas Program (MTOP), following referral from the RANZCR Particle Therapy Referral Committee.

Comparative planning of proton and photon treatment is a pre-requisite for all funding applications to ensure that the referral decision is evidence-based and objective.

The Royal Adelaide Hospital (RAH) team has been working on proton planning with multiple treatment planning systems since 2014, while gaining international experience through training and collaboration with experts in the field. The team is happy to be able to offer a national comparative planning service to assist in the decision making and referral of patients overseas for proton therapy treatment.

More information on comparative planning and contact details for the team can be found via the link below.